Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Taysha Gene Therapies

Request full access

On a mission to eradicate monogenic CNS disease

Dallas, United StatesFounded 2020Biotech & Life Sciences

About Taysha Gene Therapies

Taysha Gene Therapies is a clinical-stage biotechnology company that focuses on developing and commercializing adeno-associated virus (AAV)-based gene therapies for severe monogenic diseases of the central nervous system (CNS). The company is dedicated to eradicating or treating severe and life-threatening monogenic diseases affecting the CNS.

As a clinical-stage company, Taysha Gene Therapies is actively engaged in clinical trials to test the safety and efficacy of its therapeutic candidates. The company's business model is centered on the research and development of these gene therapies, with the ultimate goal of obtaining regulatory approval and bringing them to market. Its primary clients are patients suffering from these rare and severe neurological conditions. The company operates in the biotechnology and pharmaceutical market, a highly regulated and competitive industry.

Source: Dealroom company data

At a glance

Status
Listed
Listing
IPO 2020

Taysha Gene Therapies in the Dallas ecosystem

Live from Dealroom

The Taysha Gene Therapies office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

17 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed2 investors entered at this stage

  • PBM Capital Group
  • Nolan Capital

Series A10 investors entered at this stage

Series B and later5 investors entered at this stage

  • Standard Treasury
  • Silicon Valley Bank
  • Astellas Pharma
  • Trinity Capital
  • Capricorn Fund Managers
Team profiled 13 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 6 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

See Taysha Gene Therapies on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.